Compare TransMedics Group Inc (TMDX) vs Wynn Resorts, Limited (WYNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TransMedics Group Inc vs Wynn Resorts, Limited — how do they compare? TransMedics Group Inc trades at $77.87 (market cap $2.74B), while Wynn Resorts, Limited trades at $75.15 (market cap $7.75B). The key difference: Wynn Resorts, Limited is far larger — about 2.8× TransMedics Group Inc's market cap, and Wynn Resorts, Limited pays a 1.33% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold TransMedics Group Inc for 24 Days and Wynn Resorts, Limited for 76 Days on average.
| TMDX | WYNN | |
|---|---|---|
Market Cap | $2.74B | $7.75B |
Volume | 949,331 | 2,243,813 |
Sector | Health | Consumer Cyclical |
52-Week High | $150.42 | $133.09 |
52-Week Low | $61.99 | $74.97 |
Typical Hold Time | 24 Days | 76 Days |
Enterprise Value | $3.13B | $17.99B |
Dividend Yield | — | 1.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TransMedics Group (TMDX) trades at $77.87, down 3.95% on the day, amid a bearish technical signal and recent earnings misses. The company maintains strong profitability with a 22.69% net income margin and 36.28% ROE, though 2026 projections show margin compression. Analyst consensus remains bullish with a $99.75 price target, but sentiment is clouded by multiple legal investigations into fiduciary duties announced in late August and September 2026.
The stock faces near-term pressure from technical weakness and legal overhangs, but solid fundamentals and analyst conviction suggest long-term potential if execution improves. Key risks include ongoing legal scrutiny, margin pressures from heavy investment, and volatility around future earnings reports.
Wynn Resorts (WYNN) trades at $75.15, up 0.24% on the day, with a bearish technical signal driven by moving averages. The company reported mixed Q2 2026 earnings, beating EPS estimates but showing margin pressure in the U.S. Revenue growth is supported by Macau strength, though high capital expenditure for new projects in the UAE and elevated debt levels present financial risks. Analyst consensus remains strongly bullish with a $132.36 price target, but recent institutional activity shows mixed positioning.
The outlook for WYNN hinges on Macau recovery and successful execution of expansion projects, offering potential upside from current levels. However, risks include rising capex, competitive pressures, and macroeconomic sensitivity. Investors should weigh strong analyst sentiment against fundamental challenges and debt load.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →About Wynn Resorts, Limited
Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, Encore Boston Harbor in Massachusetts opened June 2019. Additionally, we expect the company to begin construction on a new building next to its existing Macao Palace resort in 2023, which we forecast to open in 2026. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and Las Vegas, respectively.
Read more on WYNN →
